All News

The clinical trial success in canines may have broader implications for applicability.

If health care professionals want to increase access and care in these underrepresented communities, an important first step is also increasing the representation of those groups in health care itself.

Health promotional strategies should account for social contexts and cultural perspectives to increase the number of individuals who choose to test for HIV.

Pre-exposure prophylaxis found to provide peace of mind for patients at risk of HIV, and coupled with frequent HIV testing in the health care setting, lowers the perceived risk of contracting the disease.

Pharmacy Times will be providing exclusive session coverage and interviews with presenters for the Academy of Managed Care Pharmacy Nexus 2023 conference.

A single-center experience at a tertiary medical center precision medicine clinic provides insight.

Study shows that interventions may help to personalize care that meets the individual needs of patients with HIV and to improve mental health outcomes.

Primary care physicians, particularly in family medicine, offer PrEP at a significantly low rate, despite US Preventive Services Task Force recommendations.

Continuous innovation is required in various technological aspects to effectively manage the challenges of vast clinical data.

Study authors suggest that immunocompromised patients may greatly benefit from nirmatrelvir and ritonavir; however, there was no significant benefit shown in lower-risk patients.

Investigators hope that continued research and addressing disparities can improve equitable access to asthma treatments for all pediatric patients.

With walkouts across the country and other efforts to raise public awareness, pharmacists are working to find solutions to understaffing and workload challenges.

Community pharmacies are ideal locations to identify and recruit underrepresented patients for clinical trials.

Within this care model, pharmacists can serve an important role in caring for patients, whether it is identifying adverse medication interactions or pushing patients to seek additional support.

Providing clinical trials at community locations allows patients with travel restrictions to access novel treatments that are typically studied academic institutions.

Individuals treated with esketamine were more likely to reach remission and remain relapse-free at 8 weeks of treatment.

Use of antidepressants and other classes of prescription drugs can increase the risk of driving impairment compared to nonuse, so clinicians and pharmacists should review these risks with older adults.

Parents are not fully educated on the risk of meningitis infection and preventive efforts for their children.

In the first systematic review using statistical methods, investigators found switching from a reference biologic to a biosimilar was comparable in safety, but no conclusion on immunogenicity could be drawn.

The intravenous formulation of secukinumab is administered in monthly 30-minute, weight-based dosing and requires no pre-medication or lab monitoring.

Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.

Tune in to this episode of Pharmacy Focus: Student Edition to discover how innovative programs like Western University's 3.5-year pharmacy program are shaping the future of pharmacy education.

Roflumilast is the first topical agent indicated to treat psoriasis in sensitive intertriginous areas of the skin.

Expert discuss access barriers for the COVID-19, respiratory syncytial virus, and influenza vaccines, and ways to facilitate uptake.

Choice of therapy should be selected based on patient needs and conditions.

Harmful LDL functionality contributes to an increase of cardiovascular disease in those with obesity but could decrease within weight loss.

The use of psilocybin, repeated at a low dose, could offer a new form of treatment for individuals with differing forms of mental disorders.

Not only did the Navya-Patient Preference Tool help patients with decision-making, but groups who used the tool were more likely to receive their preferred form of surgery.